Related Experiment Video
Updated: May 18, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection
Takashi Himoto1, Tsutomu Masaki
1Department of Gastroenterology and Neurology, Kagawa University School of Medicine, Kagawa, Japan. thimoto@med.kagawa-u.ac.jp
Insights
Chronic hepatitis C virus (HCV) infection is linked to autoimmune disorders and metabolic issues. This study explores the connection between HCV-related extrahepatic manifestations and the development of autoantibodies, highlighting their clinical significance.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Chronic hepatitis C virus (HCV) infection is associated with numerous extrahepatic manifestations.
- These often include autoimmune disorders (e.g., cryoglobulinemia, Sjögren's syndrome, autoimmune thyroiditis) and lymphoproliferative disorders.
- HCV infection is known to induce both non-organ-specific and organ-specific autoantibodies.
Purpose of the Study:
- To investigate the relationship between extrahepatic manifestations in HCV patients and the emergence of autoantibodies.
- To discuss the clinical relevance and significance of these autoantibodies in HCV-associated extrahepatic disorders.
Main Methods:
- Review of existing literature on HCV infection, extrahepatic manifestations, and autoantibody production.
- Analysis of the association between specific autoantibodies and clinical manifestations.
- Discussion of the diagnostic and prognostic value of autoantibodies in HCV patients.
Main Results:
- Chronic HCV infection frequently leads to the production of various autoantibodies.
- A significant correlation exists between specific autoantibodies and distinct extrahepatic manifestations.
- The clinical significance of these autoantibodies in understanding HCV pathogenesis is increasingly recognized.
Conclusions:
- Autoantibodies play a crucial role in the pathogenesis of HCV-related extrahepatic manifestations.
- Monitoring autoantibody profiles can aid in diagnosing and managing these conditions.
- Further research is warranted to fully elucidate the clinical utility of autoantibodies in chronic hepatitis C.
Abstract:
Patients with chronic hepatitis C virus (HCV) infection frequently have many extrahepatic manifestations, as persistent HCV infection often triggers lymphoproliferative disorders and metabolic abnormalities. These manifestations primarily include autoimmune disorders such as cryoglobulinemia, Sjögren's syndrome, and autoimmune thyroid disorders. It has been well established that chronic HCV infection plays important roles in the production of non-organ-specific autoantibodies, including antinuclear antibodies and smooth muscle antibodies, and organ-specific autoantibodies such as thyroid autoantibodies. However, the clinical significance of autoantibodies associated with the extrahepatic manifestations caused by HCV infection has not been fully recognized. In this paper, we mainly focus on the relationship between extrahepatic manifestations and the emergence of autoantibodies in patients with HCV infection and discuss the clinical relevance of the autoantibodies in the extrahepatic disorders.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...

